Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128283 · ClinicalTrials.gov registry record
Indicators of Inflammation and Coagulation in Sepsis
A clinical trial of Sepsis, sponsored by University of Oklahoma.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01128283 is a study of Sepsis that has completed, run by University of Oklahoma. The registered enrollment target is 500 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01128283, a study of Sepsis, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.
Conditions Studied
Study Locations (1)
Oklahoma
- OU Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2002-01 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01128283
The ClinicalTrials.gov registry entry for NCT01128283 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT01128283 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01128283 about?
NCT01128283 is a clinical study titled "Indicators of Inflammation and Coagulation in Sepsis". We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.
What is the current status of trial NCT01128283?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2002-01. Estimated completion is 2014-05.
What conditions does trial NCT01128283 study?
This clinical trial studies the following conditions: Sepsis.
Who is sponsoring clinical trial NCT01128283?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01128283 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.